These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25687684)

  • 1. The molecular basis for functional plasticity in type I interferon signaling.
    Schreiber G; Piehler J
    Trends Immunol; 2015 Mar; 36(3):139-49. PubMed ID: 25687684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons and viruses: an evolutionary arms race of molecular interactions.
    Hoffmann HH; Schneider WM; Rice CM
    Trends Immunol; 2015 Mar; 36(3):124-38. PubMed ID: 25704559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic control of type I IFN signalling by an integrated network of negative regulators.
    Porritt RA; Hertzog PJ
    Trends Immunol; 2015 Mar; 36(3):150-60. PubMed ID: 25725583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What have we learned from the IL28 receptor knockout mouse?
    Mordstein M; Michiels T; Staeheli P
    J Interferon Cytokine Res; 2010 Aug; 30(8):579-84. PubMed ID: 20649452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.
    Xu HC; Grusdat M; Pandyra AA; Polz R; Huang J; Sharma P; Deenen R; Köhrer K; Rahbar R; Diefenbach A; Gibbert K; Löhning M; Höcker L; Waibler Z; Häussinger D; Mak TW; Ohashi PS; Lang KS; Lang PA
    Immunity; 2014 Jun; 40(6):949-60. PubMed ID: 24909887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons as Essential Modulators of Atherosclerosis.
    Boshuizen MC; de Winther MP
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1579-88. PubMed ID: 25953648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and activity of the porcine type I interferon family.
    Sang Y; Rowland RR; Hesse RA; Blecha F
    Physiol Genomics; 2010 Jul; 42(2):248-58. PubMed ID: 20406849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.
    Piehler J; Thomas C; Garcia KC; Schreiber G
    Immunol Rev; 2012 Nov; 250(1):317-34. PubMed ID: 23046138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of type III interferons to antiviral immunity: location, location, location.
    Kotenko SV; Durbin JE
    J Biol Chem; 2017 May; 292(18):7295-7303. PubMed ID: 28289095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferons (alpha/beta) in immunity and autoimmunity.
    Theofilopoulos AN; Baccala R; Beutler B; Kono DH
    Annu Rev Immunol; 2005; 23():307-36. PubMed ID: 15771573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
    Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A
    Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication.
    Collado-Hidalgo A; Sung C; Cole S
    Brain Behav Immun; 2006 Nov; 20(6):552-63. PubMed ID: 16504464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling.
    Kirby D; Parmar B; Fathi S; Marwah S; Nayak CR; Cherepanov V; MacParland S; Feld JJ; Altan-Bonnet G; Zilman A
    Front Immunol; 2021; 12():748423. PubMed ID: 34691060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering with immunity: detrimental role of type I IFNs during infection.
    Stifter SA; Feng CG
    J Immunol; 2015 Mar; 194(6):2455-65. PubMed ID: 25747907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes.
    Pinschewer DD; Flatz L; Steinborn R; Horvath E; Fernandez M; Lutz H; Suter M; Bergthaler A
    Int Immunol; 2010 Sep; 22(9):749-56. PubMed ID: 20584765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
    Ozato K; Tsujimura H; Tamura T
    Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.
    Honda K; Takaoka A; Taniguchi T
    Immunity; 2006 Sep; 25(3):349-60. PubMed ID: 16979567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III interferons in innate and adaptive immunity in the respiratory tract.
    Piperakis A; Galani IE; Andreakos E
    Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.